4.8 Article

Atomic force microscopy combined with human pluripotent stem cell derived cardiomyocytes for biomechanical sensing

Journal

BIOSENSORS & BIOELECTRONICS
Volume 85, Issue -, Pages 751-757

Publisher

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2016.05.073

Keywords

Micromechanical biosensor; Human stem cell; Cardiomyocyte contraction; Drug testing

Funding

  1. CEITEC - Central European Institute of Technology [CZ.1.05/1.1.00/02.0068, LQ1601]
  2. FNUSA-ICRC from European Regional Development Fund [CZ.1.05/1.1.00/ 02.0123, LQ1605]
  3. National Program of Sustainability II., Grant Agency of the Czech Republic [P302/12/G157, GA13-19910S]
  4. SoMoPro - Marie Curie Actions - South Moravian Region
  5. European Society of Cardiology (ESC) [R12042FF]

Ask authors/readers for more resources

Cardiomyocyte contraction and relaxation are important parameters of cardiac function altered in many heart pathologies. Biosensing of these parameters represents an important tool in drug development and disease modeling. Human embryonic stem cells and especially patient specific induced pluripotent stem cell-derived cardiomyocytes are well established as cardiac disease model.. Here, a live stem cell derived embryoid body (EB) based cardiac cell syncytium served as a biorecognition element coupled to the microcantilever probe from atomic force microscope thus providing reliable micromechanical cellular biosensor suitable for whole-day testing. The biosensor was optimized regarding the type of cantilever, temperature and exchange of media; in combination with standardized protocol, it allowed testing of compounds and conditions affecting the biomechanical properties of EB. The studied effectors included calcium, drugs modulating the catecholaminergic fight-or-flight stress response such as the beta-adrenergic blocker metoprolol and the beta-adrenergic agonist isoproterenol. Arrhythmogenic effects were studied using caffeine. Furthermore, with EBs originating from patient's stem cells, this biosensor can help to characterize heart diseases such as dystrophies. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available